Vosoritide for children with idiopathic short stature
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a medication called vosoritide to see if it can help children with unexplained short stature grow taller. It's for kids who are very short for their age but have normal growth hormone levels and no other known cause.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child's height is much shorter than average for their age and sex (more than 2.25 standard deviations below the average).
- If your child is 5 or older, they have not started puberty yet.
- Your child has had a normal growth hormone test result (a stimulation test over 10, or a normal IGF-1 level).
- Your child does not have a known genetic condition causing short stature (like Turner syndrome or Noonan syndrome).
- Your child has never been treated with growth hormone or other growth-promoting medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an investigational drug can help children with idiopathic short stature (short height with no known cause) grow taller. It may be an option for children who are very short for their age and have not responded well to standard growth hormone therapy.
This trial tests an investigational drug called GenSci134 for children with idiopathic short stature (short height with no known cause). It aims to see if the drug can help them grow taller. The study is for children who have not been treated with growth hormones before.
This study tests a new growth hormone injection (Inpegsomatropin) to help children with idiopathic short stature (short stature with no known cause) grow taller. It may be an option if your child is very short compared to peers and has not started puberty.
This trial tests a weekly growth hormone injection (lonapegsomatropin) compared to the standard daily growth hormone shot in children with short stature due to certain conditions. It aims to see if the weekly shot works as well or better and is safe.
This trial studies the long-term safety and effectiveness of Growtropin®-II, a growth hormone–type injection, in children who are short due to certain causes. It may help your child’s growth over time, while also closely tracking side effects.
This trial tests a new drug, vosoritide, to help children with Noonan syndrome who are still growing but are shorter than expected despite growth hormone treatment. It aims to see if the drug can improve their growth.
Hear when a new Idiopathic Short Stature trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.